Year: 2005
Type: article
Abstract: This Task Force report by the American College of Neuropsychopharmacology evaluates the safety and efficacy of selective serotonin reuptake inhibitor (SSRIs) antidepressants for depressed youth under 18 years. The report was undertaken after regulatory agencies in the United States and United Kingdom raised concerns in 2003 about the possibility that treatment of depression in children and adolescents with SSRIs may increase the risk of suicidal thinking or suicide attempts.
Source: Neuropsychopharmacology
Institutions: New York State Psychiatric Institute, Columbia University, The University of Texas at Dallas, The University of Texas Southwestern Medical Center, Harvard University, McLean Hospital, Boston Children's Hospital, University of New Mexico, George Washington University, Cornell University, Weill Cornell Medicine, Vanderbilt University Medical Center, University of Pittsburgh, The University of Texas Medical Branch at Galveston
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,290
OpenAlex ID: W2017340637